Kamada Ltd. (KMDA)
8.43
+0.19
(+2.31%)
USD |
NASDAQ |
Aug 24, 16:00
8.43
0.00 (0.00%)
After-Hours: 07:29
Kamada Price to Book Value : 1.804 for Aug. 24, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 24, 2026 | 1.804 |
| August 21, 2026 | 1.764 |
| August 20, 2026 | 1.716 |
| August 19, 2026 | 1.689 |
| August 18, 2026 | 1.689 |
| August 17, 2026 | 1.661 |
| August 14, 2026 | 1.622 |
| August 13, 2026 | 1.554 |
| August 12, 2026 | 1.472 |
| August 11, 2026 | 1.518 |
| August 10, 2026 | 1.528 |
| August 07, 2026 | 1.556 |
| August 06, 2026 | 1.528 |
| August 05, 2026 | 1.537 |
| August 04, 2026 | 1.571 |
| August 03, 2026 | 1.548 |
| July 31, 2026 | 1.528 |
| July 30, 2026 | 1.520 |
| July 29, 2026 | 1.500 |
| July 28, 2026 | 1.511 |
| July 27, 2026 | 1.496 |
| July 24, 2026 | 1.511 |
| July 23, 2026 | 1.490 |
| July 22, 2026 | 1.500 |
| July 21, 2026 | 1.558 |
| Date | Value |
|---|---|
| July 20, 2026 | 1.518 |
| July 17, 2026 | 1.509 |
| July 16, 2026 | 1.479 |
| July 15, 2026 | 1.530 |
| July 14, 2026 | 1.556 |
| July 13, 2026 | 1.535 |
| July 10, 2026 | 1.524 |
| July 09, 2026 | 1.530 |
| July 08, 2026 | 1.558 |
| July 07, 2026 | 1.565 |
| July 06, 2026 | 1.603 |
| July 02, 2026 | 1.605 |
| July 01, 2026 | 1.610 |
| June 30, 2026 | 1.571 |
| June 29, 2026 | 1.637 |
| June 26, 2026 | 1.615 |
| June 25, 2026 | 1.597 |
| June 24, 2026 | 1.587 |
| June 23, 2026 | 1.586 |
| June 22, 2026 | 1.599 |
| June 18, 2026 | 1.626 |
| June 17, 2026 | 1.615 |
| June 16, 2026 | 1.659 |
| June 15, 2026 | 1.659 |
| June 12, 2026 | 1.655 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| BioLineRx Ltd. | 0.7829 |
| XTL Biopharmaceuticals Ltd. | -- |
| Can-Fite BioPharma Ltd. | 2.432 |
| Galmed Pharmaceuticals Ltd. | 0.2396 |
| Revium Recovery, Inc. | -- |
Price to Book Value Related Metrics
| PE Ratio | 22.09 |
| PS Ratio | 2.581 |
| PEG Ratio | 1.429 |
| Price to Free Cash Flow | 17.92 |
| Price | 8.43 |
| Earnings Yield | 4.53% |
| Market Cap | 486.36M |
| PEGY Ratio | 1.199 |
| Operating PE Ratio | 17.80 |
| Normalized PE Ratio | 21.53 |